Medigus and HC Marbella International Hospital Announce First MUSE Procedure for GERD Treatment in Spain

Medigus (NASDAQ:MDGS) (TASE:MDGS), a medical device company developing minimally invasive endosurgical tools and an innovator in direct visualization technology, along with High Care Marbella International Hospital, today announced the completion of the first MUSE procedure in Spain. The procedure was performed by Dr. Victor Aguilar at HC Marbella International Hospital. Dr. Aguilar reported that the procedure was successful and the patient was released from the hospital.

As quoted in the press release:

“It’s extremely exciting to see Dr. Aguilar pioneer the procedure in another key market for the MUSE system,” said Chris Rowland, Chief Executive Officer of Medigus. “We are looking to build on the physician interest of the MUSE procedure at Marbella, and expand availability in other areas of Europe in the future.”

The MUSE system is a single-use flexible transoral stapler that merges the latest advancement in microvisual, ultrasonic and surgical stapling. The device comes equipped with an ultrasonic sight and range finder and a micro ScoutCam™ CMOS camera, which enables a single physician to perform an incisionless transoral fundoplication, the procedure intended to treat the anatomical cause of gastroesophageal reflux disease (GERD). As the device requires no incisions, patients generally report greater comfort during the procedure and experience reduced hospital stays by up to 50% over invasive fundoplication procedures.

Click here to read the full press release.